WELLS FARGO & COMPANY/MN - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q3 2023$25,920
-31.5%
12,832
-0.0%
0.00%
Q2 2023$37,861
-18.7%
12,834
-31.1%
0.00%
Q1 2023$46,590
+16.6%
18,636
+47.8%
0.00%
Q4 2022$39,974
+8.0%
12,610
-0.5%
0.00%
Q3 2022$37,000
-7.5%
12,677
-3.5%
0.00%
Q2 2022$40,000
-81.5%
13,138
-17.9%
0.00%
Q1 2022$216,000
-39.0%
16,007
-41.2%
0.00%
Q4 2021$354,000
+35300.0%
27,230
+27130.0%
0.00%
Q3 2021$1,000
-97.8%
100
-97.8%
0.00%
Q2 2021$46,000
-72.5%
4,578
-49.7%
0.00%
Q1 2021$167,000
-48.5%
9,106
-3.4%
0.00%
Q4 2020$324,0009,4280.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 714,763$2,265,7992.16%
Perceptive Advisors 4,797,278$15,207,3710.43%
Potomac Capital Management, Inc. 80,000$2540.30%
Bristlecone Advisors, LLC 696,629$2,208,3140.27%
TANG CAPITAL MANAGEMENT LLC 485,234$1,538,1920.22%
RA Capital Management 1,881,300$5,963,7210.12%
GSA CAPITAL PARTNERS LLP 270,989$8590.11%
PATHSTONE FAMILY OFFICE, LLC 3,631,080$8,182,6500.07%
Laird Norton Wetherby Trust Company, LLC 130,000$412,1000.06%
Forefront Analytics, LLC 22,350$70,8510.04%
View complete list of ATHIRA PHARMA INC shareholders